Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study

(2017) Cheryl Cohen et al.   Lancet Global Health

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study

(2017) Eric D. McCollum et al.   PLoS One

Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media

(2016) Stefan Flasche et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children

(2016) Harish Nair et al.   BMC INFECTIOUS DISEASES

Long-term Impact of a “3 + 0” Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002–2014

(2016) Sanjay Jayasinghe et al.   CLINICAL INFECTIOUS DISEASES

Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine

(2016) L. Georgalis et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case–control study

(2016) Marcela Guevara et al.   Eurosurveillance

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

(2016) Grant A Mackenzie et al.   LANCET INFECTIOUS DISEASES

Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan

(2016) Wei-Ju Su et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature

(2016) Niv Segal et al.   VACCINE

Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda

(2016) Maurice Gatera et al.   VACCINE

Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance

(2016) Sabrina Sgambatti et al.   VACCINE

Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea

(2016) Young June Choe et al.   VACCINE

Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses

(2016) Victor Suarez et al.   VACCINE

Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD

(2016) S. Ben-Shimol et al.   VACCINE

Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions

(2016) Robert Cohen et al.   VACCINE

Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden

(2016) Ann Lindstrand et al.   VACCINE

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis

(2016) Ana Lucia Andrade et al.   Human Vaccines & Immunotherapeutics

Interim results of an ecological experiment — Conjugate vaccination against the pneumococcus and serotype replacement

(2016) William P Hausdorff et al.   Human Vaccines & Immunotherapeutics

Evaluation of the Impact of Pneumococcal Conjugate Vaccine on Pediatric Community-Acquired Pneumonia Using an Emergency Database System

(2016) Guilhem Noel et al.   Journal of the Pediatric Infectious Diseases Society

Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data

(2016) Janepsy Diaz et al.   PLoS One

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany

(2016) Mark van der Linden et al.   PLoS One

Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review

(2016) Lucia Helena de Oliveira et al.   PLoS One

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced

(2015) Qiuzhi Chang et al.   BMC INFECTIOUS DISEASES

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany

(2015) Matthias Imöhl et al.   BMC INFECTIOUS DISEASES

Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil

(2015) Indianara Maria Grando et al.   Cadernos de Saude Publica

Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children

(2015) Corinne Levy et al.   CLINICAL INFECTIOUS DISEASES

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children

(2015) Liset Olarte et al.   CLINICAL INFECTIOUS DISEASES

Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco

(2015) Idrissa Diawara et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine

(2015) Tatiane E. Hirose et al.   Jornal de Pediatria

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Corrections

(2015)   LANCET INFECTIOUS DISEASES

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

(2015) Ajoke Sobanjo-ter Meulen et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pediatric Invasive Pneumococcal Disease in Taiwan Following a National Catch-up Program With the 13-Valent Pneumococcal Conjugate Vaccine

(2015) Sung-Hsi Wei et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease

(2015) A. A. Palmu et al.   PEDIATRICS

Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci

(2015) P. K. Mitchell et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation

(2015) Nina Katharina Stock et al.   PLoS One

Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case–control study

(2015) Shabir A Madhi et al.   THORAX

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

(2015) Gili Regev-Yochay et al.   VACCINE

Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children

(2015) David Greenberg et al.   VACCINE

Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom

(2015) Wallis C.Y. Lau et al.   VACCINE

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

(2015) Emmanuelle Varon et al.   VACCINE

A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation

(2015) Robert Cohen et al.   VACCINE

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

(2015) A. Lepoutre et al.   VACCINE

Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease

(2015) Jennifer R. Verani et al.   VACCINE

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

(2015) Geneviève Deceuninck et al.   VACCINE

The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience

(2015) Shabir A Madhi et al.   Human Vaccines & Immunotherapeutics

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries

(2015) Gail L Rodgers et al.   Human Vaccines & Immunotherapeutics

Serotype distribution ofStreptococcus pneumoniaein children with invasive diseases in Turkey: 2008–2014

(2015) Mehmet Ceyhan et al.   Human Vaccines & Immunotherapeutics

Rationale and prospects for novel pneumococcal vaccines

(2015) Kristin Moffitt et al.   Human Vaccines & Immunotherapeutics

Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012

(2015) Andrea C. Farnham et al.   JAMA Pediatrics

Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study

(2015) Jukka Jokinen et al.   PLoS One

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

(2015) Mark van der Linden et al.   PLoS One

The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development

(2015) M Nadeem Khan et al.   Human Vaccines & Immunotherapeutics

Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children

(2014) F. Angoulvant et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in HIV-Infected and -Uninfected Children in South Africa: A Matched Case-Control Study

(2014) Cheryl Cohen et al.   CLINICAL INFECTIOUS DISEASES

Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV

(2014) Shalom Ben-Shimol et al.   CLINICAL INFECTIOUS DISEASES

Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality

(2014) Zitta Barrella Harboe et al.   CLINICAL INFECTIOUS DISEASES

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types

(2014) Sarah Browall et al.   EUROPEAN RESPIRATORY JOURNAL

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa

(2014) Anne von Gottberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changes in Hospitalizations for Pneumonia After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay

(2014) María Catalina Pírez et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France

(2014) Corinne Levy et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in Nicaragua

(2014) Sylvia Becker-Dreps et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Sinusitis and Pneumonia Hospitalization After Introduction of Pneumococcal Conjugate Vaccine

(2014) Ann Lindstrand et al.   PEDIATRICS

Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine

(2014) P.-Y. I. Tam et al.   PEDIATRICS

Impact of Pneumococcal Conjugate Vaccines on the Incidence of Pneumonia in Hospitalized Children after Five Years of Its Introduction in Uruguay

(2014) María Hortal et al.   PLoS One

All-Cause Pneumonia Hospitalizations in Children

(2014) Anders Berglund et al.   PLoS One

Effect of Pneumococcal Conjugate Vaccination in Uruguay, a Middle-Income Country

(2014) Gabriela García Gabarrot et al.   PLoS One

Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction

(2014) Marcelo Comerlato Scotta et al.   VACCINE

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children

(2014) Shalom Ben-Shimol et al.   VACCINE

Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial

(2014) A A Palmu et al.   Lancet Respiratory Medicine

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

(2014) Lone Simonsen et al.   Lancet Respiratory Medicine

Editorial Commentary: The Challenge of Preventing Invasive Pneumococcal Disease in Children With Comorbid Illnesses

(2013) S. I. Pelton   CLINICAL INFECTIOUS DISEASES

Invasive Pneumococcal Disease, Comorbidities, and Polysaccharide Vaccine Use in Children Aged 5-15 Years in England and Wales

(2013) S. N. Ladhani et al.   CLINICAL INFECTIOUS DISEASES

Competition Between Streptococcus Pneumoniae Strains

(2013) Juha Mehtälä et al.   EPIDEMIOLOGY

Surface Charge of Streptococcus pneumoniae Predicts Serotype Distribution

(2013) Yuan Li et al.   INFECTION AND IMMUNITY

Mixed Pneumococcal–Nontypeable Haemophilus influenzae Otitis Media Is a Distinct Clinical Entity With Unique Epidemiologic Characteristics and Pneumococcal Serotype Distribution

(2013) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

(2013) Sheldon L. Kaplan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization

(2013) Jennifer D. Loo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Nasopharyngeal Carriage of Pneumococci Four Years after Community-Wide Vaccination with PCV-7 in The Gambia: Long-Term Evaluation of a Cluster Randomized Trial

(2013) Anna Roca et al.   PLoS One

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

(2013) Daniel R. Feikin et al.   PLOS MEDICINE

Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France

(2012) Robert Cohen et al.   BMC INFECTIOUS DISEASES

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

(2012) Catherine Weil-Olivier et al.   BMC INFECTIOUS DISEASES

Issues and challenges in the development of pneumococcal protein vaccines

(2012) Amy Sarah Ginsburg et al.   Expert Review of Vaccines

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis

(2011) Debby Bogaert et al.   PLoS One

High Levels of Recombination among Streptococcus pneumoniae Isolates from the Gambia

(2011) E. S. Donkor et al.   mBio

Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study

(2011) Stefan Flasche et al.   PLOS MEDICINE

Nasopharyngeal Carriage of Individual Streptococcus pneumoniae Serotypes During Pediatric Pneumonia as a Means to Estimate Serotype Disease Potential

(2010) David Greenberg et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

(2010) Germaine Hanquet et al.   VACCINE

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

(2010) Inci Yildirim et al.   VACCINE

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease

(2009) W.P. Hausdorff et al.   VACCINE

Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence

(2009) Daniel M. Weinberger et al.   PLoS Pathogens

Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997-2004

(2008) F. Zhou et al.   PEDIATRICS